EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 92 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,493 | -82.4% | 14,730 | -59.3% | 0.00% | – |
| Q2 2023 | $25,493 | -49.8% | 36,211 | -36.1% | 0.00% | – |
| Q1 2023 | $50,819 | +211.8% | 56,661 | +310.2% | 0.00% | – |
| Q4 2022 | $16,299 | -90.1% | 13,813 | -47.3% | 0.00% | – |
| Q2 2022 | $165,000 | -77.8% | 26,188 | -70.7% | 0.00% | – |
| Q1 2022 | $742,000 | +56.5% | 89,400 | -2.0% | 0.00% | – |
| Q4 2021 | $474,000 | +5.1% | 91,271 | +35.1% | 0.00% | – |
| Q3 2021 | $451,000 | +295.6% | 67,563 | +501.2% | 0.00% | – |
| Q4 2018 | $114,000 | – | 11,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |